<scp>CD</scp>4 T cells in protection from influenza virus: Viral antigen specificity and functional potential
Andrea J. Sant(University of Rochester Medical Center), Katherine A. Richards(University of Rochester Medicine), Jennifer L. Nayak(University of Rochester Medicine), Ajitanuj Rattan(University of Rochester Medicine), Anthony DiPiazza(Moderna Therapeutics (United States))
Cited by 93
Related Papers
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
|Cell|2021|309
The Kinetic Stability of MHC Class II:Peptide Complexes Is a Key Parameter that Dictates Immunodominance
|Immunity|2005|232
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
|Science|2021|216
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
|bioRxiv (Cold Spring Harbor Laboratory)|2020|143